[{"Assets_0_FY_USD":193263000.0,"CommonStockSharesOutstanding_0_FY_shares":109862787.0,"EarningsPerShareBasic_1_FY_USD":0.05,"EarningsPerShareBasic_4_FY_USD":0.11,"EarningsPerShareDiluted_1_FY_USD":0.05,"EarningsPerShareDiluted_4_FY_USD":0.11,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":25828000.0,"NetIncomeLoss_1_FY_USD":5481000.0,"NetIncomeLoss_4_FY_USD":11974000.0,"StockholdersEquity_0_FY_USD":133000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":112441709.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":105928348.0,"Ticker":"MDXG","CIK":"1376339","name":"MIMEDX GROUP, INC.","OfficialName":"MiMedx Group Inc Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"515730569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170301"}]